Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-09

Clinical Trial Update: Different Immunosuppressive Treatment in iMN [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating different immunosuppressive regimens for idiopathic membranous nephropathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Idiopathic Membranous Nephropathy | Phase 3 | Status: RECRUITING